董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Xiaomin Chen | 男 | Chairman of the Board and Chief Executive Officer and Director | 49 | 3.00万美元 | 27.00 | 2026-10-13 |
| Mingyue Cai | 男 | Independent Director | 48 | 1.20万美元 | 未持股 | 2026-10-13 |
| Jing Zhang | 女 | Independent Director | 47 | 1.20万美元 | 未持股 | 2026-10-13 |
| Mingze Yin | 男 | Chief Financial Officer and Director | 36 | 12.00万美元 | 未持股 | 2026-10-13 |
| Cheang I Kei | 女 | Independent Director | 30 | 0.80万美元 | 未持股 | 2026-10-13 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Xiaomin Chen | 男 | Chairman of the Board and Chief Executive Officer and Director | 49 | 3.00万美元 | 27.00 | 2026-10-13 |
| Mingze Yin | 男 | Chief Financial Officer and Director | 36 | 12.00万美元 | 未持股 | 2026-10-13 |
董事简历
中英对照 | 中文 | 英文- Xiaomin Chen
-
陈晓敏自2026年4月28日起担任Advanced Biomed Inc.首席执行官、Advanced Biomed Inc.董事会成员和Advanced Biomed Inc.董事会主席。陈博士在人工智能、大语言模型和金融科技领域拥有超过20年的经验。自2019年以来，陈博士一直担任Acellent的首席执行官，该公司于2026年4月30日成为Advanced Biomed Inc.的全资子公司，在那里他领导了Acellent的金融领域大语言模型（FinLLM）和FinTruth AI验证系统的开发。2010年至2019年，陈博士担任上海剑石网络科技有限公司首席技术官。2006年至2010年，他是谷歌公司Core Search & AI团队的软件工程师，并于2009年获得谷歌年度杰出贡献奖。陈博士于2006年获得罗格斯大学计算机科学博士学位，1998年获得上海交通大学计算机科学理学学士学位。
Xiaomin Chen has served as Advanced Biomed Inc.'s Chief Executive Officer, a member of Advanced Biomed Inc.'s board of directors and the Chairman of Advanced Biomed Inc.'s board of directors since April 28, 2026. Dr. Chen has over 20 years of experience in artificial intelligence, large language models and financial technology. Since 2019, Dr. Chen has served as the Chief Executive Officer of Acellent, which became Advanced Biomed Inc.'s wholly owned subsidiary on April 30, 2026, where he has led the development of Acellent's financial domain large language model (FinLLM) and the FinTruth AI verification system. From 2010 to 2019, Dr. Chen served as the Chief Technology Officer of Shanghai Jianshi Network Technology Co., Ltd. From 2006 to 2010, he was a software engineer on the Core Search & AI team at Google Inc., where he received Google's Annual Outstanding Contribution Award in 2009. Dr. Chen received a Ph.D. in Computer Science from Rutgers University in 2006 and a Bachelor of Science degree in Computer Science from Shanghai Jiao Tong University in 1998. - 陈晓敏自2026年4月28日起担任Advanced Biomed Inc.首席执行官、Advanced Biomed Inc.董事会成员和Advanced Biomed Inc.董事会主席。陈博士在人工智能、大语言模型和金融科技领域拥有超过20年的经验。自2019年以来，陈博士一直担任Acellent的首席执行官，该公司于2026年4月30日成为Advanced Biomed Inc.的全资子公司，在那里他领导了Acellent的金融领域大语言模型（FinLLM）和FinTruth AI验证系统的开发。2010年至2019年，陈博士担任上海剑石网络科技有限公司首席技术官。2006年至2010年，他是谷歌公司Core Search & AI团队的软件工程师，并于2009年获得谷歌年度杰出贡献奖。陈博士于2006年获得罗格斯大学计算机科学博士学位，1998年获得上海交通大学计算机科学理学学士学位。
- Xiaomin Chen has served as Advanced Biomed Inc.'s Chief Executive Officer, a member of Advanced Biomed Inc.'s board of directors and the Chairman of Advanced Biomed Inc.'s board of directors since April 28, 2026. Dr. Chen has over 20 years of experience in artificial intelligence, large language models and financial technology. Since 2019, Dr. Chen has served as the Chief Executive Officer of Acellent, which became Advanced Biomed Inc.'s wholly owned subsidiary on April 30, 2026, where he has led the development of Acellent's financial domain large language model (FinLLM) and the FinTruth AI verification system. From 2010 to 2019, Dr. Chen served as the Chief Technology Officer of Shanghai Jianshi Network Technology Co., Ltd. From 2006 to 2010, he was a software engineer on the Core Search & AI team at Google Inc., where he received Google's Annual Outstanding Contribution Award in 2009. Dr. Chen received a Ph.D. in Computer Science from Rutgers University in 2006 and a Bachelor of Science degree in Computer Science from Shanghai Jiao Tong University in 1998.
- Mingyue Cai
-
Mingyue Cai于2020年2月25日被任命为董事会董事。Cai先生曾任深圳市Yitu安全技术有限公司副总裁，该公司是一家从事人工智能开发和应用的中国公司。2009年11月至2017年8月，他在如皋港口集团有限公司（Rugao Port Group Co.，Ltd.）担任行政总监，该公司是一家专注于港口物流、工业园区建设和木材、煤炭和矿石贸易的中国公司。2004年6月至2009年10月，Cai先生在上海Rishan环保科技有限公司担任经理，该公司是一家经销和零售环保清洁产品的中国公司。Cai先生拥有行政管理学士学位。
Mingyue Cai has served as Advanced Biomed Inc.'s independent director and the Chair of the Nominating and Corporate Governance Committee since February 2025. Mr. Cai has been the Vice President at Yitu Safety Technology (Shenzhen) Co., Ltd., a PRC company engages in artificial intelligence development and application. From February 2020 to April 2024, Mr. Cai worked as an independent director and the chair of compensation committee of GD Culture Group Limited (NASDAQ: GDC). From November 2009 to August 2017, he was an administrative director at Rugao Port Group Co., Ltd., a PRC company that focuses on port logistics, industrial park construction and timber, coal and ore trade. From June 2004 to October 2009, Mr. Cai worked as a manager at Shanghai Rishan Environmental Protection Technology Co., Ltd., a PRC company that distribute and retail environmentally friendly cleaning products. Mr. Cai graduated from China Central Radio & TV University in 2015 with a major in administration. - Mingyue Cai于2020年2月25日被任命为董事会董事。Cai先生曾任深圳市Yitu安全技术有限公司副总裁，该公司是一家从事人工智能开发和应用的中国公司。2009年11月至2017年8月，他在如皋港口集团有限公司（Rugao Port Group Co.，Ltd.）担任行政总监，该公司是一家专注于港口物流、工业园区建设和木材、煤炭和矿石贸易的中国公司。2004年6月至2009年10月，Cai先生在上海Rishan环保科技有限公司担任经理，该公司是一家经销和零售环保清洁产品的中国公司。Cai先生拥有行政管理学士学位。
- Mingyue Cai has served as Advanced Biomed Inc.'s independent director and the Chair of the Nominating and Corporate Governance Committee since February 2025. Mr. Cai has been the Vice President at Yitu Safety Technology (Shenzhen) Co., Ltd., a PRC company engages in artificial intelligence development and application. From February 2020 to April 2024, Mr. Cai worked as an independent director and the chair of compensation committee of GD Culture Group Limited (NASDAQ: GDC). From November 2009 to August 2017, he was an administrative director at Rugao Port Group Co., Ltd., a PRC company that focuses on port logistics, industrial park construction and timber, coal and ore trade. From June 2004 to October 2009, Mr. Cai worked as a manager at Shanghai Rishan Environmental Protection Technology Co., Ltd., a PRC company that distribute and retail environmentally friendly cleaning products. Mr. Cai graduated from China Central Radio & TV University in 2015 with a major in administration.
- Jing Zhang
-
Jing Zhang，自2025年2月起担任独立董事、审计委员会主任委员。Zhang女士拥有超过25年的财务管理工作经验。2013年7月至今，Zhang女士担任上海Xun Yang Network Technology Co., Ltd.首席财务官。2022年9月至2023年2月，Zhang女士担任Code Chain New Continent Limited Co., Ltd.（纳斯达克股票代码：CCNC）独立董事兼审计委员会主席。2009年3月至2013年7月，Zhang女士担任Zi Guang Intelligence Co., Ltd.上海分公司财务经理。1999年3月至2009年2月，Zhang女士担任八五医院财务部会计、财务总监。Zhang女士于1999年毕业于枣庄学院。
Jing Zhang has served as Advanced Biomed Inc.'s independent director and the Chair of the Audit Committee since February 2025. Ms. Zhang has more than 25 years of working experience in financial management. Since July 2013, Ms. Zhang has been the Chief Financial Officer of Shanghai Xun Yang Network Technology Co., Ltd. From September 2022 to February 2023, Ms. Zhang served as an independent director and the chair of the audit committee of Code Chain New Continent Limited Co., Ltd. (NASDAQ: CCNC). From March 2009 to July 2013, Ms. Zhang served as the financial manager of Shanghai Branch of Jiangsu Zi Guang Intelligence Co., Ltd. From March 1999 to February 2009, Ms. Zhang served as the accountant and financial director of the Finance Department of the Eight Five Hospital. Ms. Zhang graduated from Zaozhuang University in 1999. - Jing Zhang，自2025年2月起担任独立董事、审计委员会主任委员。Zhang女士拥有超过25年的财务管理工作经验。2013年7月至今，Zhang女士担任上海Xun Yang Network Technology Co., Ltd.首席财务官。2022年9月至2023年2月，Zhang女士担任Code Chain New Continent Limited Co., Ltd.（纳斯达克股票代码：CCNC）独立董事兼审计委员会主席。2009年3月至2013年7月，Zhang女士担任Zi Guang Intelligence Co., Ltd.上海分公司财务经理。1999年3月至2009年2月，Zhang女士担任八五医院财务部会计、财务总监。Zhang女士于1999年毕业于枣庄学院。
- Jing Zhang has served as Advanced Biomed Inc.'s independent director and the Chair of the Audit Committee since February 2025. Ms. Zhang has more than 25 years of working experience in financial management. Since July 2013, Ms. Zhang has been the Chief Financial Officer of Shanghai Xun Yang Network Technology Co., Ltd. From September 2022 to February 2023, Ms. Zhang served as an independent director and the chair of the audit committee of Code Chain New Continent Limited Co., Ltd. (NASDAQ: CCNC). From March 2009 to July 2013, Ms. Zhang served as the financial manager of Shanghai Branch of Jiangsu Zi Guang Intelligence Co., Ltd. From March 1999 to February 2009, Ms. Zhang served as the accountant and financial director of the Finance Department of the Eight Five Hospital. Ms. Zhang graduated from Zaozhuang University in 1999.
- Mingze Yin
-
Mingze Yin，曾担任Advanced Biomed Inc.；自2022年11月起担任首席财务官。他一直担任Shanghai Sglcell Biotech Co.， Ltd.的首席财务官（2021年1月以来）。2017年3月至2021年12月，Yin先生担任Shanghai Guangdian Asset Management Co., Ltd.董事。2020年2月至2020年11月，他担任TMSR控股有限公司（纳斯达克股票代码：TMSR）的独立董事。2018年2月至2018年11月，Yin先生担任Planet Green Holdings Corp.（纽约证券交易所代码：PLAG）的投资者关系经理。2015年11月至2017年2月，Yin先生担任Zhongshan Securities Co., Ltd.投资银行部高级经理。2012年10月至2015年10月，他担任BDO China Shu Lun Pan会计师事务所高级审计经理。他于2011年获得江苏海洋大学管理学学士学位。
Mingze Yin has served as Advanced Biomed Inc.'s Chief Financial Officer since November 2022 and as a member of Advanced Biomed Inc.'s board of directors since March 25, 2026. He has over 11 years of experience in the financial and investment banking industry. He has been the Chief Financial Officer of Shanghai Sglcell Biotech Co., Ltd. since January 2021 and oversees its finance department. From March 2017 to December 2021, Mr. Yin was Director of Shanghai Guangdian Asset Management Co., Ltd., where he participated in all major corporate decisions and financial compliance matters. From February 2020 to November 2020, he was an independent director of TMSR Holding Company Limited (Nasdaq: TMSR) and a member of its Audit Committee, Nominating and Governance Committee, and Compensation Committee. From February 2018 to November 2018, Mr. Yin was the investors relations manager of Planet Green Holdings Corp. (NYSE: PLAG). From November 2015 to February 2017, Mr. Yin was a senior manager of the Investment Banking Department of Zhongshan Securities Co., Ltd. From October 2012 to October 2015, he was the senior audit manager of BDO China Shu Lun Pan Certified Public Accountants LLP. Mr. Yin is a certified internal auditor and obtained his Bachelor of Management from Jiangsu Haiyang University in 2011. - Mingze Yin，曾担任Advanced Biomed Inc.；自2022年11月起担任首席财务官。他一直担任Shanghai Sglcell Biotech Co.， Ltd.的首席财务官（2021年1月以来）。2017年3月至2021年12月，Yin先生担任Shanghai Guangdian Asset Management Co., Ltd.董事。2020年2月至2020年11月，他担任TMSR控股有限公司（纳斯达克股票代码：TMSR）的独立董事。2018年2月至2018年11月，Yin先生担任Planet Green Holdings Corp.（纽约证券交易所代码：PLAG）的投资者关系经理。2015年11月至2017年2月，Yin先生担任Zhongshan Securities Co., Ltd.投资银行部高级经理。2012年10月至2015年10月，他担任BDO China Shu Lun Pan会计师事务所高级审计经理。他于2011年获得江苏海洋大学管理学学士学位。
- Mingze Yin has served as Advanced Biomed Inc.'s Chief Financial Officer since November 2022 and as a member of Advanced Biomed Inc.'s board of directors since March 25, 2026. He has over 11 years of experience in the financial and investment banking industry. He has been the Chief Financial Officer of Shanghai Sglcell Biotech Co., Ltd. since January 2021 and oversees its finance department. From March 2017 to December 2021, Mr. Yin was Director of Shanghai Guangdian Asset Management Co., Ltd., where he participated in all major corporate decisions and financial compliance matters. From February 2020 to November 2020, he was an independent director of TMSR Holding Company Limited (Nasdaq: TMSR) and a member of its Audit Committee, Nominating and Governance Committee, and Compensation Committee. From February 2018 to November 2018, Mr. Yin was the investors relations manager of Planet Green Holdings Corp. (NYSE: PLAG). From November 2015 to February 2017, Mr. Yin was a senior manager of the Investment Banking Department of Zhongshan Securities Co., Ltd. From October 2012 to October 2015, he was the senior audit manager of BDO China Shu Lun Pan Certified Public Accountants LLP. Mr. Yin is a certified internal auditor and obtained his Bachelor of Management from Jiangsu Haiyang University in 2011.
- Cheang I Kei
-
Cheang I Kei，自2025年2月11日起担任独立董事和薪酬委员会主席。她自2022年10月起担任Luso International Banking Ltd.的法律高级经理。她于2019年5月至2022年10月担任中国银行（澳门）法务经理。2016年8月至2019年5月，她担任Luso International Banking Ltd.的法律助理。她于2016年获得澳门理工大学中英文翻译和口译学士学位。
Cheang I Kei has served as Advanced Biomed Inc.'s independent director and the Chair of the Compensation Committee since February 2025. Ms. Cheang has been the legal senior manager at Luso International Banking Ltd. since October 2022. She served as the legal manager at Bank of China (Macau) from May 2019 to October 2022. She was the legal assistant at Luso International Banking Ltd. between August 2016 and May 2019. Ms. Cheang received her bachelor's degree in Chinese English translation and interpretation from Macau Polytechnic University in 2016. - Cheang I Kei，自2025年2月11日起担任独立董事和薪酬委员会主席。她自2022年10月起担任Luso International Banking Ltd.的法律高级经理。她于2019年5月至2022年10月担任中国银行（澳门）法务经理。2016年8月至2019年5月，她担任Luso International Banking Ltd.的法律助理。她于2016年获得澳门理工大学中英文翻译和口译学士学位。
- Cheang I Kei has served as Advanced Biomed Inc.'s independent director and the Chair of the Compensation Committee since February 2025. Ms. Cheang has been the legal senior manager at Luso International Banking Ltd. since October 2022. She served as the legal manager at Bank of China (Macau) from May 2019 to October 2022. She was the legal assistant at Luso International Banking Ltd. between August 2016 and May 2019. Ms. Cheang received her bachelor's degree in Chinese English translation and interpretation from Macau Polytechnic University in 2016.
高管简历
中英对照 | 中文 | 英文- Xiaomin Chen
陈晓敏自2026年4月28日起担任Advanced Biomed Inc.首席执行官、Advanced Biomed Inc.董事会成员和Advanced Biomed Inc.董事会主席。陈博士在人工智能、大语言模型和金融科技领域拥有超过20年的经验。自2019年以来，陈博士一直担任Acellent的首席执行官，该公司于2026年4月30日成为Advanced Biomed Inc.的全资子公司，在那里他领导了Acellent的金融领域大语言模型（FinLLM）和FinTruth AI验证系统的开发。2010年至2019年，陈博士担任上海剑石网络科技有限公司首席技术官。2006年至2010年，他是谷歌公司Core Search & AI团队的软件工程师，并于2009年获得谷歌年度杰出贡献奖。陈博士于2006年获得罗格斯大学计算机科学博士学位，1998年获得上海交通大学计算机科学理学学士学位。
Xiaomin Chen has served as Advanced Biomed Inc.'s Chief Executive Officer, a member of Advanced Biomed Inc.'s board of directors and the Chairman of Advanced Biomed Inc.'s board of directors since April 28, 2026. Dr. Chen has over 20 years of experience in artificial intelligence, large language models and financial technology. Since 2019, Dr. Chen has served as the Chief Executive Officer of Acellent, which became Advanced Biomed Inc.'s wholly owned subsidiary on April 30, 2026, where he has led the development of Acellent's financial domain large language model (FinLLM) and the FinTruth AI verification system. From 2010 to 2019, Dr. Chen served as the Chief Technology Officer of Shanghai Jianshi Network Technology Co., Ltd. From 2006 to 2010, he was a software engineer on the Core Search & AI team at Google Inc., where he received Google's Annual Outstanding Contribution Award in 2009. Dr. Chen received a Ph.D. in Computer Science from Rutgers University in 2006 and a Bachelor of Science degree in Computer Science from Shanghai Jiao Tong University in 1998.- 陈晓敏自2026年4月28日起担任Advanced Biomed Inc.首席执行官、Advanced Biomed Inc.董事会成员和Advanced Biomed Inc.董事会主席。陈博士在人工智能、大语言模型和金融科技领域拥有超过20年的经验。自2019年以来，陈博士一直担任Acellent的首席执行官，该公司于2026年4月30日成为Advanced Biomed Inc.的全资子公司，在那里他领导了Acellent的金融领域大语言模型（FinLLM）和FinTruth AI验证系统的开发。2010年至2019年，陈博士担任上海剑石网络科技有限公司首席技术官。2006年至2010年，他是谷歌公司Core Search & AI团队的软件工程师，并于2009年获得谷歌年度杰出贡献奖。陈博士于2006年获得罗格斯大学计算机科学博士学位，1998年获得上海交通大学计算机科学理学学士学位。
- Xiaomin Chen has served as Advanced Biomed Inc.'s Chief Executive Officer, a member of Advanced Biomed Inc.'s board of directors and the Chairman of Advanced Biomed Inc.'s board of directors since April 28, 2026. Dr. Chen has over 20 years of experience in artificial intelligence, large language models and financial technology. Since 2019, Dr. Chen has served as the Chief Executive Officer of Acellent, which became Advanced Biomed Inc.'s wholly owned subsidiary on April 30, 2026, where he has led the development of Acellent's financial domain large language model (FinLLM) and the FinTruth AI verification system. From 2010 to 2019, Dr. Chen served as the Chief Technology Officer of Shanghai Jianshi Network Technology Co., Ltd. From 2006 to 2010, he was a software engineer on the Core Search & AI team at Google Inc., where he received Google's Annual Outstanding Contribution Award in 2009. Dr. Chen received a Ph.D. in Computer Science from Rutgers University in 2006 and a Bachelor of Science degree in Computer Science from Shanghai Jiao Tong University in 1998.
- Mingze Yin
Mingze Yin，曾担任Advanced Biomed Inc.；自2022年11月起担任首席财务官。他一直担任Shanghai Sglcell Biotech Co.， Ltd.的首席财务官（2021年1月以来）。2017年3月至2021年12月，Yin先生担任Shanghai Guangdian Asset Management Co., Ltd.董事。2020年2月至2020年11月，他担任TMSR控股有限公司（纳斯达克股票代码：TMSR）的独立董事。2018年2月至2018年11月，Yin先生担任Planet Green Holdings Corp.（纽约证券交易所代码：PLAG）的投资者关系经理。2015年11月至2017年2月，Yin先生担任Zhongshan Securities Co., Ltd.投资银行部高级经理。2012年10月至2015年10月，他担任BDO China Shu Lun Pan会计师事务所高级审计经理。他于2011年获得江苏海洋大学管理学学士学位。
Mingze Yin has served as Advanced Biomed Inc.'s Chief Financial Officer since November 2022 and as a member of Advanced Biomed Inc.'s board of directors since March 25, 2026. He has over 11 years of experience in the financial and investment banking industry. He has been the Chief Financial Officer of Shanghai Sglcell Biotech Co., Ltd. since January 2021 and oversees its finance department. From March 2017 to December 2021, Mr. Yin was Director of Shanghai Guangdian Asset Management Co., Ltd., where he participated in all major corporate decisions and financial compliance matters. From February 2020 to November 2020, he was an independent director of TMSR Holding Company Limited (Nasdaq: TMSR) and a member of its Audit Committee, Nominating and Governance Committee, and Compensation Committee. From February 2018 to November 2018, Mr. Yin was the investors relations manager of Planet Green Holdings Corp. (NYSE: PLAG). From November 2015 to February 2017, Mr. Yin was a senior manager of the Investment Banking Department of Zhongshan Securities Co., Ltd. From October 2012 to October 2015, he was the senior audit manager of BDO China Shu Lun Pan Certified Public Accountants LLP. Mr. Yin is a certified internal auditor and obtained his Bachelor of Management from Jiangsu Haiyang University in 2011.- Mingze Yin，曾担任Advanced Biomed Inc.；自2022年11月起担任首席财务官。他一直担任Shanghai Sglcell Biotech Co.， Ltd.的首席财务官（2021年1月以来）。2017年3月至2021年12月，Yin先生担任Shanghai Guangdian Asset Management Co., Ltd.董事。2020年2月至2020年11月，他担任TMSR控股有限公司（纳斯达克股票代码：TMSR）的独立董事。2018年2月至2018年11月，Yin先生担任Planet Green Holdings Corp.（纽约证券交易所代码：PLAG）的投资者关系经理。2015年11月至2017年2月，Yin先生担任Zhongshan Securities Co., Ltd.投资银行部高级经理。2012年10月至2015年10月，他担任BDO China Shu Lun Pan会计师事务所高级审计经理。他于2011年获得江苏海洋大学管理学学士学位。
- Mingze Yin has served as Advanced Biomed Inc.'s Chief Financial Officer since November 2022 and as a member of Advanced Biomed Inc.'s board of directors since March 25, 2026. He has over 11 years of experience in the financial and investment banking industry. He has been the Chief Financial Officer of Shanghai Sglcell Biotech Co., Ltd. since January 2021 and oversees its finance department. From March 2017 to December 2021, Mr. Yin was Director of Shanghai Guangdian Asset Management Co., Ltd., where he participated in all major corporate decisions and financial compliance matters. From February 2020 to November 2020, he was an independent director of TMSR Holding Company Limited (Nasdaq: TMSR) and a member of its Audit Committee, Nominating and Governance Committee, and Compensation Committee. From February 2018 to November 2018, Mr. Yin was the investors relations manager of Planet Green Holdings Corp. (NYSE: PLAG). From November 2015 to February 2017, Mr. Yin was a senior manager of the Investment Banking Department of Zhongshan Securities Co., Ltd. From October 2012 to October 2015, he was the senior audit manager of BDO China Shu Lun Pan Certified Public Accountants LLP. Mr. Yin is a certified internal auditor and obtained his Bachelor of Management from Jiangsu Haiyang University in 2011.